The Novel Conjugates Summit is the only industry-led forum dedicated entirely to novel payload and targeting format innovation in antibody-drug conjugate (ADC) development. It brings together the discovery, bioconjugation and R&D scientists working on the next generation of conjugates, with no traditional ADC content on the agenda.

Now in its 6th year, the summit unites 80+ leaders from big pharma, ADC biotech and novel conjugate biotech to share new data, benchmark approaches and work through the translational challenges of taking differentiated conjugates toward the clinic.

Explore The Agenda - 5th Novel Conjugates Summit
Explore the Agenda

Preview data-led sessions on dual-payload, pathway-directed, degrader and bispecific conjugates, and two pre-conference workshops on rational design and preclinical signposts. Download the event guide for the full agenda and speaker faculty across three days.

Partner With Us - 5th Novel Conjugates Summit
Partner With Us
Meet 80+ discovery, bioconjugation and R&D leaders who are choosing partners for dual-payload, degrader, bispecific and non-antibody programs. Extend your reach beyond the flagship ADC meetings into a room where every attendee is focused on what comes next and inquire to see the partnership options.
Conjugates Experts - 5th Novel Conjugates Summit
Join the Community
Join 80+ scientists driving novel conjugate development, from big pharma discovery teams to emerging biotechs, in a single-track meeting with time to speak with everyone in the room. Download the guide or inquire to secure your place.